BioTime, Inc. is a clinical-stage biotechnology company headquartered in Alameda, California. BioTime stock is traded on the New York Stock Exchange American Exchange under ticker symbol BTX. BioTime focuses primarily on aesthetics, ophthalmology and cell and drug delivery. The company is in clinical trials for dry age-related macular degeneration (dry AMD) and facial lipoatrophy in HIV patients.
Fremont, CA, United States.
UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Asterias Biotherapeutics is implementing good security practices.
Read more about the latest issues in cybersecurity
A vendor risk management questionnaire (also known as a third-party risk assessment questionnaire ...
For many businesses, global third-party vendors have become an important source of strategic ...
Compare Asterias Biotherapeutics's security performance with other companies